Bausch Health Companies
BHC
$0.07 (-1.22%)
1D
1W
3M
1Y
5Y
ALL
Bausch Health Companies Inc. is a specialty pharmaceutical and medical device company. The Company develops, manufactures, and markets, primarily in the therapeutic areas of eye health, gastroenterology (GI), and dermatology, a range of branded, generic and branded generic pharmaceuticals, over the counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices) which are marketed directly or indirectly in approximately 100 countries. The Company operates through five segments: Bausch + Lomb, Salix, International, Solta Medical, and Diversified Products. The Bausch + Lomb segment consists of global sales of Bausch + Lomb Vision Care, Consumer, Surgical, and Ophthalmic Pharmaceuticals products. The Salix segment consists of sales in the United States of gastrointestinal (GI) products. The Solta Medical segment consists of global sales of Solta aesthetic medical devices.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
The Motley Fool • 3 days ago • BHC
Why Bausch Health Companies Was Crawling Higher This Week
Zacks Investment Research • 3 days ago • BHC
BHC Q1 Earnings Miss Estimates, Sales Grow on Salix & Solta Strength
Seeking Alpha • 4 days ago • BHC
Bausch Health Companies Inc. (BHC) Q1 2026 Earnings Call Transcript
Zacks Investment Research • 4 days ago • BHC
Bausch Health (BHC) Lags Q1 Earnings Estimates
Zacks Investment Research • 4 days ago • BHC
Compared to Estimates, Bausch (BHC) Q1 Earnings: A Look at Key Metrics
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.